Literature DB >> 18167178

Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome.

Bai-cang Zou1, Lei Dong, Yan Wang, Sheng-hao Wang, Ming-bo Cao.   

Abstract

BACKGROUND: The 5-hydroxytryptamine7 receptor (5-HT(7) receptor, 5-HT(7)R) plays an important role in the regulation of smooth muscle relaxation and visceral sensation and might be involved in the pathogenesis of the gastrointestinal dyskinesia, abdominal pain and visceral paresthesia in irritable bowel syndrome (IBS). The aim of this study was to investigate the role of the 5-HT(7) receptor in the pathogenesis of IBS.
METHODS: A rat model of irritable bowel syndrome with diarrhea (IBS-D) was established by colonic instillation of acetic acid and restraint stress. A rat model with irritable bowel syndrome with constipation (IBS-C) was established by stomach irrigated with 0 - 4 degrees C cool water daily for 14 days. The content and distribution of 5-HT in the brain and gut were examined by immunohistochemistry and the mRNA expression of the 5-HT(7) receptor was determined by fluorescent quantitative reverse transcription polymerase chain reaction. The accumulation of cyclic adenosine monophosphate (cAMP) in all the same tissues was measured by radioimmunity.
RESULTS: The models of IBS were reliable by identification. The immunohistochemistry results showed that there were significantly more 5-HT positive cells in the IBS-D group than in the control group in the hippocampus, hypothalamus, jejunum, ileum, proximate colon and distal colon (P < 0.05), as well as more than were found in the IBS-C group in jejunum and ileum (P < 0.05). There were more 5-HT positive cells in the IBS-C group than in the control hippocampus, hypothalamus, ileum, proximate colon, and distal colon (P < 0.05). Real time-PCR results showed that the expression level of the 5-HT(7) receptor in both the IBS-C and IBS-D groups were enhanced compared with the control group in the hippocampus and hypothalamus (P < 0.05). The expression level of 5-HT(7) receptors in the IBS-C group was notably greater when compared with the controls in the ileum and colon (P < 0.05). The cAMP accumulation in the hippocampus and hypothalamus in both the IBS-C and IBS-D groups was higher than that in the control group (P < 0.01 and P < 0.05). The cAMP accumulation in the IBS-C group was higher than that in the control group in the proximal and distal colon (P < 0.05).
CONCLUSIONS: The increased 5-HT content in the brain and intestine is related to the IBS pathogenesis. The up-regulated expression of the 5-HT(7) receptor in the brain and colon might play an important role in the pathogenesis of IBS-C.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18167178

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  13 in total

1.  Serotonin disrupts esophageal mucosal integrity: an investigation using a stratified squamous epithelial model.

Authors:  Liping Wu; Tadayuki Oshima; Toshihiko Tomita; Yoshio Ohda; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2016-03-16       Impact factor: 7.527

2.  Development of a novel mouse constipation model.

Authors:  Chao Liang; Kai-Yue Wang; Zhi Yu; Bin Xu
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

3.  Characteristics of deslanoside-induced modulation on jejunal contractility.

Authors:  Da-Peng Chen; Yong-Jian Xiong; Ze-Yao Tang; Qi-Ying Yao; Dong-Mei Ye; Sha-Sha Liu; Yuan Lin
Journal:  World J Gastroenterol       Date:  2012-11-07       Impact factor: 5.742

4.  Brain-Gut Interactions in IBS.

Authors:  Jakub Fichna; Martin A Storr
Journal:  Front Pharmacol       Date:  2012-07-05       Impact factor: 5.810

5.  Characteristics of diprophylline-induced bidirectional modulation on rat jejunal contractility.

Authors:  Fang-Fei Liu; Da-Peng Chen; Yong-Jian Xiong; Bo-Chao Lv; Yuan Lin
Journal:  Korean J Physiol Pharmacol       Date:  2014-02-13       Impact factor: 2.016

Review 6.  5-HT7 receptor signaling: improved therapeutic strategy in gut disorders.

Authors:  Janice J Kim; Waliul I Khan
Journal:  Front Behav Neurosci       Date:  2014-12-11       Impact factor: 3.558

7.  Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats.

Authors:  Changchun Yu; Yongjian Xiong; Dapeng Chen; Yanli Li; Bin Xu; Yuan Lin; Zeyao Tang; Chunling Jiang; Li Wang
Journal:  Korean J Physiol Pharmacol       Date:  2016-12-21       Impact factor: 2.016

8.  The injury of serotonin on intestinal epithelium cell renewal of weaned diarrhoea mice.

Authors:  Y Dong; C Yang; Z Wang; Z Qin; J Cao; Y Chen
Journal:  Eur J Histochem       Date:  2016-12-28       Impact factor: 3.188

Review 9.  Functions and Signaling Pathways of Amino Acids in Intestinal Inflammation.

Authors:  Fang He; Chenlu Wu; Pan Li; Nengzhang Li; Dong Zhang; Quoqiang Zhu; Wenkai Ren; Yuanyi Peng
Journal:  Biomed Res Int       Date:  2018-02-26       Impact factor: 3.411

Review 10.  Dysfunction in Serotonergic and Noradrenergic Systems and Somatic Symptoms in Psychiatric Disorders.

Authors:  Yi Liu; Jingping Zhao; Xiaoduo Fan; Wenbin Guo
Journal:  Front Psychiatry       Date:  2019-05-21       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.